Biomarkers in Alzheimer's disease
Frontiers | Amyloid-β Peptide Impact on Synaptic Function and Neuroepigenetic Gene Control Reveal New Therapeutic Strategies for Alzheimer's Disease
Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a Model of Alzheimer's Disease - ScienceDirect
-Immunohistochemistry-Paraffin-NBP2-13075-img0015.jpg "beta Amyloid Antibody (MOAB-2) - BSA Free (NBP2-13075): Novus Biologicals")
beta Amyloid Antibody (MOAB-2) - BSA Free (NBP2-13075): Novus Biologicals
Biomedicines | Free Full-Text | Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline? | PLOS Biology
Refining the amyloid β peptide and oligomer fingerprint ambiguities in Alzheimer's disease: Mass spectrometric molecular characterization in brain, cerebrospinal fluid, blood, and plasma - Michno - 2021 - Journal of Neurochemistry - Wiley Online Library
Mechanism of amyloid-β (Aβ) removal via Aβ-specific antibodies. FcR =... | Download Scientific Diagram
The Amyloid-β Pathway in Alzheimer's Disease | Molecular Psychiatry
Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer's Disease | PLOS ONE
The complexity of Alzheimer's disease: an evolving puzzle | Physiological Reviews
Secreted Amyloid β-Proteins in a Cell Culture Model Include N-Terminally Extended Peptides That Impair Synaptic Plasticity | Biochemistry
Frontiers | Ophthalmic Biomarkers for Alzheimer's Disease: A Review
Amyloid-β42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer's disease | Nature Communications
Cells | Free Full-Text | Circular RNA Encoded Amyloid Beta peptides—A Novel Putative Player in Alzheimer's Disease
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models: Cell
IJMS | Free Full-Text | Amyloid Beta in Aging and Alzheimer’s Disease
Amyloid-β: A double agent in Alzheimer's disease? - ScienceDirect
Amyloid Hypothesis vs Tau Hypothesis | StressMarq
Clinically accurate diagnosis of Alzheimer's disease via multiplexed sensing of core biomarkers in human plasma | Nature Communications
The Amyloid-β Pathway in Alzheimer's Disease | Molecular Psychiatry
Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy - IOS Press
Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches - The Lancet Neurology
Diagnostics | Free Full-Text | Nanobiosensors for Non-Amyloidbeta-Tau Biomarkers as Advanced Reporters of Alzheimer's Disease
Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease | Nature Medicine
